Affinage · Toxoplasma gondii

AMA4

EGF family domain-containing protein · UniProt A0A125YRE5

Annotated
2026-09-10
6 papers in source corpus 3 papers cited in narrative 3 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TgAMA4 is a divergent apical membrane antigen of Toxoplasma gondii that drives host cell invasion at the moving junction during specific life-cycle stages by pairing with its coevolved rhoptry-neck partner TgRON2L1 (PMID:26712012, PMID:36693095). It was first implicated as a functionally redundant member of the AMA family: disruption of AMA1 upregulates AMA4 and RON2 homologues that together sustain residual invasion, revealing molecular plasticity at the moving junction (PMID:24934579). TgAMA4 forms a high-affinity complex with TgRON2L1, and crystal structures of apo and ligand-bound forms show it lacks both the deep surface groove and the surface loop that govern RON2 selectivity in canonical AMAs, defining an unexpected binding architecture; the interface was mapped by alanine scanning, and TgAMA4 clusters phylogenetically with Plasmodium MAEBL proteins (PMID:26712012). Functionally, AMA4 and RON2L1 constitute the moving junction of the bradyzoite stage, replacing the tachyzoite AMA1-RON2 pair, and conditional loss of AMA4 reduces cyst burden at the onset of chronic infection while remaining dispensable for the acute phase; immunization with the AMA4-RON2L1 complex confers selective protection against chronic toxoplasmosis (PMID:36693095).

Mechanistic history

Synthesis pass · year-by-year structured walk · 3 steps
  1. 2014 Medium

    It was unknown whether the AMA1-RON2 moving junction was uniquely essential; disruption of AMA1 revealed that AMA4 and other AMA-RON homologues can be upregulated to support residual invasion, establishing functional redundancy and plasticity at the moving junction.

    Evidence Reverse genetics (AMA1 gene disruption) with invasion-assay readout in T. gondii

    PMID:24934579

    Open questions at the time
    • AMA4 involvement was inferred from upregulation without a direct AMA4 knockout
    • Did not establish the native stage or context in which AMA4 normally functions
    • No direct demonstration of an AMA4-RON pairing
  2. 2015 High

    The molecular basis of AMA4-RON2 pairing was unknown; crystal structures of TgAMA4 apo and TgRON2L1-bound forms plus mutagenesis defined a high-affinity complex with an unexpected architecture lacking the canonical AMA groove and surface loop, showing AMA4 uses a distinct assembly mechanism.

    Evidence X-ray crystallography of apo and ligand-bound complex, alanine-scanning mutagenesis, binding-affinity and phylogenetic analysis in T. gondii

    PMID:26712012

    Open questions at the time
    • In vivo function and stage-specific role were not established at this point
    • Structural work was based on sporozoite expression; bradyzoite relevance not yet shown
    • Basis of coevolution with RON2L1 not functionally tested in infection
  3. 2023 High

    The physiological role of AMA4 was unresolved; conditional loss-of-function showed AMA4-RON2L1 forms the bradyzoite moving junction, replacing the tachyzoite AMA1-RON2 pair, and is required for cyst burden during chronic but not acute infection, with the complex serving as a stage-selective vaccine antigen.

    Evidence Conditional knockout/knockdown, invasion assays, acute/chronic mouse infection models, and immunization experiments in T. gondii

    PMID:36693095

    Open questions at the time
    • Mechanism of stage-specific AMA4/RON2L1 expression switching not defined
    • Whether residual acute-phase invasion uses other AMA-RON pairs not resolved here
    • Structural basis of the bradyzoite junction in the intact parasite not shown

Open questions

Synthesis pass · forward-looking unresolved questions
  • How AMA4-RON2L1 expression is restricted to the bradyzoite (and sporozoite) stages, and how the moving-junction hand-off between AMA-RON pairs is regulated across the life cycle, remains unresolved in the available corpus.
  • No transcriptional/regulatory mechanism for stage-specific AMA4 expression identified
  • No structural model of the AMA4 junction in situ during invasion
  • Full complement of AMA4-interacting rhoptry and micronemal proteins not mapped

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Partners
Complex memberships
TgAMA4-TgRON2L1 moving junction complex

Evidence

Reading pass · 3 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2014 AMA1 gene disruption in T. gondii results in upregulation of AMA1 homologues (including AMA4) and RON2 homologues that cooperate to support residual invasion, demonstrating molecular plasticity at the moving junction and functional redundancy among AMA-RON pairs. Reverse genetics (gene disruption), invasion assays Nature communications Medium 24934579
2015 TgAMA4 forms a high-affinity functional complex with its coevolved partner TgRON2L1. Crystal structures of TgAMA4 in apo and TgRON2L1-bound forms revealed that TgAMA4 lacks both the deep surface groove and the key surface loop that govern RON2 ligand-binding selectivity in canonical AMAs, defining an unexpected architecture and assembly mechanism. Alanine scanning mutagenesis confirmed the functional interface. TgAMA4 phylogenetically clusters with Plasmodium MAEBL proteins and is expressed in sporozoites. X-ray crystallography (apo and ligand-bound structures), alanine scanning mutagenesis, phylogenetic analysis, binding affinity assays Proceedings of the National Academy of Sciences of the United States of America High 26712012
2023 AMA4 is expressed in bradyzoites and forms part of the moving junction during bradyzoite host cell invasion together with its partner RON2L1, functionally replacing the tachyzoite AMA1-RON2 pair. Conditional loss-of-function of AMA4 demonstrated its key role in cyst burden during the onset of chronic infection while being dispensable for the acute phase. Immunization with the AMA4-RON2L1 complex provided selective protection against the chronic form of toxoplasmosis. Reverse genetics (gene knockout/conditional knockdown), invasion assays, mouse infection model (acute and chronic), immunization/vaccination experiments Proceedings of the National Academy of Sciences of the United States of America High 36693095

Source papers

Stage 0 corpus · 6 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2014 Plasticity and redundancy among AMA-RON pairs ensure host cell entry of Toxoplasma parasites. Nature communications 128 24934579
2008 Infection with Toxoplasma gondii results in dysregulation of the host cell cycle. Cellular microbiology 70 18182087
2015 Dissecting the interface between apicomplexan parasite and host cell: Insights from a divergent AMA-RON2 pair. Proceedings of the National Academy of Sciences of the United States of America 29 26712012
2023 Invasion of Toxoplasma gondii bradyzoites: Molecular dissection of the moving junction proteins and effective vaccination targets. Proceedings of the National Academy of Sciences of the United States of America 24 36693095
2013 Enzymatically active Rho and Rac small-GTPases are involved in the establishment of the vacuolar membrane after Toxoplasma gondii invasion of host cells. BMC microbiology 18 23721065
2018 Resveratrol-mediated reversal of changes in purinergic signaling and immune response induced by Toxoplasma gondii infection of neural progenitor cells. Purinergic signalling 15 30535987